Discovery of Small Molecules as Membrane-Bound Catechol-O-methyltransferase Inhibitors with Interest in Parkinson’s Disease: Pharmacophore Modeling, Molecular Docking and In Vitro Experimental Validation Studies

A pharmacophore-based virtual screening methodology was used to discover new catechol-O-methyltransferase (COMT) inhibitors with interest in Parkinson’s disease therapy. To do so, pharmacophore models were constructed using the structure of known inhibitors and then they were used in a screening in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz-Vicente, Pedro, Gonçalves, Ana M., Ferreira, Octávio, Queiroz, João A., Silvestre, Samuel, Passarinha, Luís A., Gallardo, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780549/
https://www.ncbi.nlm.nih.gov/pubmed/35056108
http://dx.doi.org/10.3390/ph15010051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780549/
https://www.ncbi.nlm.nih.gov/pubmed/35056108
http://dx.doi.org/10.3390/ph15010051

Ejemplares similares